Multitype Infections With Human Papillomavirus

Impact of Human Immunodeficiency Virus Coinfection

Leslie Massad, Marla J. Keller, Xianhong Xie, Howard Minkoff, Joel Palefsky, Gypsyamber DʼSouza, Christine Colie, Maria Villacres, Howard Strickler

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

BACKGROUND: Human immunodeficiency virus (HIV) infection predisposes women to genital coinfection with human papillomaviruses (HPVs). Concurrent infection with multiple HPV types has been documented, but its frequency, correlates, and impact on development of precancer are poorly defined in HIV-seropositive women. METHODS: Human immunodeficiency virus-seropositive women and -seronegative comparison women were enrolled in a cohort study and followed every 6 months from 1994 to 2006. Cervicovaginal lavage samples were tested for HPV types using polymerase chain reaction amplification with MY09/MY11 consensus primers followed by hybridization with consensus and HPV type-specific probes. Analyses were performed using generalized estimating equations. RESULTS: Multitype HPV infections were found in 594 (23%) of 2543 HIV-seropositive women and 49 (5%) of 895 HIV-seronegative women (P < 0.0001). Compared with HPV uninfected women, those with multiple concurrent HPV infections were more likely to be younger, nonwhite, and current smokers, with lower CD4 counts and HIV RNA levels. The average proportion of women with multitype HPV infections across visits was 21% in HIV-seropositive women and 3% in HIV-seronegative women (P <0.0001). Compared with infection with 1 oncogenic HPV type, multitype concurrent infection with at least 1 other HPV type at baseline did not measurably increase the risk of ever having cervical intraepithelial neoplasia 3+ detected during follow-up (odds ratio, 0.80; 95% confidence interval, 0.32–2.03, P = 0.65). CONCLUSIONS: Concurrent multitype HPV infection is common in HIV-seropositive women and frequency rises as CD4 count declines, but multitype infection does not increase precancer risk.

Original languageEnglish (US)
JournalSexually Transmitted Diseases
DOIs
StateAccepted/In press - Aug 18 2016

Fingerprint

Coinfection
HIV
Infection
Papillomavirus Infections
CD4 Lymphocyte Count
Cervical Intraepithelial Neoplasia
Therapeutic Irrigation
Virus Diseases
Cohort Studies
Odds Ratio
RNA
Confidence Intervals
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Medicine(all)
  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Multitype Infections With Human Papillomavirus : Impact of Human Immunodeficiency Virus Coinfection. / Massad, Leslie; Keller, Marla J.; Xie, Xianhong; Minkoff, Howard; Palefsky, Joel; DʼSouza, Gypsyamber; Colie, Christine; Villacres, Maria; Strickler, Howard.

In: Sexually Transmitted Diseases, 18.08.2016.

Research output: Contribution to journalArticle

Massad, Leslie ; Keller, Marla J. ; Xie, Xianhong ; Minkoff, Howard ; Palefsky, Joel ; DʼSouza, Gypsyamber ; Colie, Christine ; Villacres, Maria ; Strickler, Howard. / Multitype Infections With Human Papillomavirus : Impact of Human Immunodeficiency Virus Coinfection. In: Sexually Transmitted Diseases. 2016.
@article{2f6e4c1b4b9a4b94965c782f9eda800c,
title = "Multitype Infections With Human Papillomavirus: Impact of Human Immunodeficiency Virus Coinfection",
abstract = "BACKGROUND: Human immunodeficiency virus (HIV) infection predisposes women to genital coinfection with human papillomaviruses (HPVs). Concurrent infection with multiple HPV types has been documented, but its frequency, correlates, and impact on development of precancer are poorly defined in HIV-seropositive women. METHODS: Human immunodeficiency virus-seropositive women and -seronegative comparison women were enrolled in a cohort study and followed every 6 months from 1994 to 2006. Cervicovaginal lavage samples were tested for HPV types using polymerase chain reaction amplification with MY09/MY11 consensus primers followed by hybridization with consensus and HPV type-specific probes. Analyses were performed using generalized estimating equations. RESULTS: Multitype HPV infections were found in 594 (23{\%}) of 2543 HIV-seropositive women and 49 (5{\%}) of 895 HIV-seronegative women (P < 0.0001). Compared with HPV uninfected women, those with multiple concurrent HPV infections were more likely to be younger, nonwhite, and current smokers, with lower CD4 counts and HIV RNA levels. The average proportion of women with multitype HPV infections across visits was 21{\%} in HIV-seropositive women and 3{\%} in HIV-seronegative women (P <0.0001). Compared with infection with 1 oncogenic HPV type, multitype concurrent infection with at least 1 other HPV type at baseline did not measurably increase the risk of ever having cervical intraepithelial neoplasia 3+ detected during follow-up (odds ratio, 0.80; 95{\%} confidence interval, 0.32–2.03, P = 0.65). CONCLUSIONS: Concurrent multitype HPV infection is common in HIV-seropositive women and frequency rises as CD4 count declines, but multitype infection does not increase precancer risk.",
author = "Leslie Massad and Keller, {Marla J.} and Xianhong Xie and Howard Minkoff and Joel Palefsky and Gypsyamber DʼSouza and Christine Colie and Maria Villacres and Howard Strickler",
year = "2016",
month = "8",
day = "18",
doi = "10.1097/OLQ.0000000000000501",
language = "English (US)",
journal = "Sexually Transmitted Diseases",
issn = "0148-5717",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Multitype Infections With Human Papillomavirus

T2 - Impact of Human Immunodeficiency Virus Coinfection

AU - Massad, Leslie

AU - Keller, Marla J.

AU - Xie, Xianhong

AU - Minkoff, Howard

AU - Palefsky, Joel

AU - DʼSouza, Gypsyamber

AU - Colie, Christine

AU - Villacres, Maria

AU - Strickler, Howard

PY - 2016/8/18

Y1 - 2016/8/18

N2 - BACKGROUND: Human immunodeficiency virus (HIV) infection predisposes women to genital coinfection with human papillomaviruses (HPVs). Concurrent infection with multiple HPV types has been documented, but its frequency, correlates, and impact on development of precancer are poorly defined in HIV-seropositive women. METHODS: Human immunodeficiency virus-seropositive women and -seronegative comparison women were enrolled in a cohort study and followed every 6 months from 1994 to 2006. Cervicovaginal lavage samples were tested for HPV types using polymerase chain reaction amplification with MY09/MY11 consensus primers followed by hybridization with consensus and HPV type-specific probes. Analyses were performed using generalized estimating equations. RESULTS: Multitype HPV infections were found in 594 (23%) of 2543 HIV-seropositive women and 49 (5%) of 895 HIV-seronegative women (P < 0.0001). Compared with HPV uninfected women, those with multiple concurrent HPV infections were more likely to be younger, nonwhite, and current smokers, with lower CD4 counts and HIV RNA levels. The average proportion of women with multitype HPV infections across visits was 21% in HIV-seropositive women and 3% in HIV-seronegative women (P <0.0001). Compared with infection with 1 oncogenic HPV type, multitype concurrent infection with at least 1 other HPV type at baseline did not measurably increase the risk of ever having cervical intraepithelial neoplasia 3+ detected during follow-up (odds ratio, 0.80; 95% confidence interval, 0.32–2.03, P = 0.65). CONCLUSIONS: Concurrent multitype HPV infection is common in HIV-seropositive women and frequency rises as CD4 count declines, but multitype infection does not increase precancer risk.

AB - BACKGROUND: Human immunodeficiency virus (HIV) infection predisposes women to genital coinfection with human papillomaviruses (HPVs). Concurrent infection with multiple HPV types has been documented, but its frequency, correlates, and impact on development of precancer are poorly defined in HIV-seropositive women. METHODS: Human immunodeficiency virus-seropositive women and -seronegative comparison women were enrolled in a cohort study and followed every 6 months from 1994 to 2006. Cervicovaginal lavage samples were tested for HPV types using polymerase chain reaction amplification with MY09/MY11 consensus primers followed by hybridization with consensus and HPV type-specific probes. Analyses were performed using generalized estimating equations. RESULTS: Multitype HPV infections were found in 594 (23%) of 2543 HIV-seropositive women and 49 (5%) of 895 HIV-seronegative women (P < 0.0001). Compared with HPV uninfected women, those with multiple concurrent HPV infections were more likely to be younger, nonwhite, and current smokers, with lower CD4 counts and HIV RNA levels. The average proportion of women with multitype HPV infections across visits was 21% in HIV-seropositive women and 3% in HIV-seronegative women (P <0.0001). Compared with infection with 1 oncogenic HPV type, multitype concurrent infection with at least 1 other HPV type at baseline did not measurably increase the risk of ever having cervical intraepithelial neoplasia 3+ detected during follow-up (odds ratio, 0.80; 95% confidence interval, 0.32–2.03, P = 0.65). CONCLUSIONS: Concurrent multitype HPV infection is common in HIV-seropositive women and frequency rises as CD4 count declines, but multitype infection does not increase precancer risk.

UR - http://www.scopus.com/inward/record.url?scp=84983084271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983084271&partnerID=8YFLogxK

U2 - 10.1097/OLQ.0000000000000501

DO - 10.1097/OLQ.0000000000000501

M3 - Article

JO - Sexually Transmitted Diseases

JF - Sexually Transmitted Diseases

SN - 0148-5717

ER -